Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression

Claudin-18.2 (CLDN18.2) is specifically expressed in pancreatic precancerous lesions and pancreatic ductal adenocarcinoma (PDAC). We assessed the clinical characteristics of patients with CLDN18.2-overexpressing pancreatic cancer to identify patients who might benefit from CLDN18-targeted treatment....

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Sejun, Shin, Kabsoo, Kim, In-Ho, Hong, Taeho, Kim, Younghoon, Suh, Jahee, Lee, Myungah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455540/
https://www.ncbi.nlm.nih.gov/pubmed/37629433
http://dx.doi.org/10.3390/jcm12165394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455540/
https://www.ncbi.nlm.nih.gov/pubmed/37629433
http://dx.doi.org/10.3390/jcm12165394

Ejemplares similares